Addressing variation in treatment decision-making and outcomes in patients with locally advanced and recurrent rectal cancer

Novel biomarkers for disease recurrence and personalising neoadjuvant therapy in locally recurrent rectal cancer (LRRC): establishing a biobank of tissue and liquid biopsies at a specialist exenteration centre